← Leaderboards
Hans S Spiegel
Georgetown University
$39,369
Attributed
$39,369
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$39,369 · 4
By mechanism
M01$39,369 · 4
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Nita L. Seibel$34,818
- Joseph Alphonso Bellanti$750,336
- Kevin J Cullen$20,041,785
- John L. Marshall$2,076,333
- Joyce Marie Slingerland$12,812,016
Others in their field
Top investigators on “Patient Oriented Research”
- Praduman Jain · Vignet, Inc.$103,566,231
- Larry Arthur$103,000,000
- Charles A Coltman · Southwest Oncology Group$87,961,334
- Gregory H Reaman · National Childhood Cancer Foundation$61,988,461
- Steven E Reis · University Of Pittsburgh At Pittsburgh$61,626,874
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$57,862,577
Research focus
Patient Oriented ResearchPediatric AidsAids TherapyClinical ResearchHuman SubjectChild (0-11)Antiaids AgentCombination ChemotherapyDrug Adverse EffectDrug Screening /EvaluationHepatitis BHepatitis VaccineHiv InfectionsHuman Therapy EvaluationImmune ResponseInterleukin 2Longitudinal Human StudyMeasles VaccineOutcomes ResearchPerinatalPertussis VaccineStreptococcus Pneumoniae VaccineSubcutaneous Drug AdministrationVaccine Evaluation
Grant awards (4)
ACTG 219C: Pediatric Late Outcome Protocol, version 3.0$18,071
M01 · FY2004 · RR
PHASE I/II TRIAL OF SUBCUTANEOUS IL-2 WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY-$16,135
M01 · FY2004 · RR
PACTG P1006: The Effects of Highly Active Antiretroviral Therapy (HAART)$4,303
M01 · FY2004 · RR
PACTG P1024: Evaluation of the Immunogenicity of Pneumococal Conjugate Vaccine$860
M01 · FY2004 · RR